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Summary
Enteropathogenic Escherichia coli (EPEC) infection
of the human small intestine induces severe watery
diarrhoea linked to a rather weak inflammatory
response despite EPEC’s in vivo capacity to disrupt
epithelial barrier function. Here, we demonstrate that
EPEC flagellin triggers the secretion of the pro-
inflammatory cytokine, interleukin (IL)-8, from small
(Caco-2) and large (T84) intestinal epithelia model
systems. Interestingly, IL-8 secretion required baso-
lateral infection of T84 cells implying that flagellin
must penetrate the epithelial barrier. In contrast,
apical infection of Caco-2 cells induced IL-8 secretion
but less potently than basolateral infections. Impor-
tantly, infection of Caco-2, but not T84 cells rapidly
inhibited IL-8 secretion by a mechanism dependent
on the delivery of effectors through a transloca-
tion system encoded on the locus of enterocyte
effacement (LEE). Moreover, EPEC prevents the
phosphorylation-associated activation of multiple
kinase pathways regulating IL-8 gene transcription
by a mechanism apparently independent of LEE-
encoded effectors and four non-LEE-encoded
effectors. Crucially, our studies reveal that EPEC
inhibits the capacity of the cells to secrete IL-8 in
response to bacterial antigens and inflammatory
cytokines prior to disrupting barrier function by a
distinct mechanism. Thus, these findings also lend
themselves to a plausible mechanism to explain the
absence of a strong inflammatory response in EPEC-
infected humans.
Introduction
Enteropathogenic Escherichia coli (EPEC) infection of
the small intestine is responsible for triggering severe
watery diarrhoea in millions of people resulting in several
hundred thousand infant deaths each year (Nataro and
Kaper, 1998; Kaper et al., 2004; Chen and Frankel, 2005).
Disease is dependent on EPEC interaction with entero-
cytes lining the small intestine triggering the localized loss
(effacement) of absorptive microvilli and accumulation of
host cytoskeletal proteins into pedestal-like structures
beneath the adherent non-invasive bacteria. The ability of
this pathogen to induce these responses is dependent on
the ~35 kb locus of enterocyte effacement (LEE) which
encodes, among other things, a type three secretion
system (TTSS), EPEC-secreted proteins (Esp), injected
‘effector’ proteins and the surface protein, Intimin (Chen
and Frankel, 2005; Dean et al., 2005). The TTSS and
EspA,B,D proteins function together to form a ‘molecular
syringe’ that delivers effector proteins (both LEE- and
non-LEE-encoded) into host cells to subvert signalling
cascades (Chen and Frankel, 2005; Dean et al., 2005;
Tobe et al., 2006). The only effector protein so far shown to
be essential for the disease process is the LEE-encoded
translocated intimin receptor (Tir) (Marches et al., 2000;
Deng et al., 2003). Delivery of Tir results in its insertion into
the host plasma membrane in a hairpin-like conformation
where its extracellular domain acts as a receptor for the
LEE-encoded outer membrane protein, Intimin, to mediate
intimate adherence (Kenny et al., 1997; Kenny, 1999). The
essential nature of the TTSS/Esp ‘molecular syringe’,
Intimin and Tir molecules in disease (Marches et al., 2000;
Deng et al., 2003) presumably reflects their roles in Tir
delivery and Tir/Intimin-mediated intimate adherence.
However, this interaction with Intimin also unleashes Tir
signalling functions leading to pedestal formation, phos-
phorylation of a host phospholipase and downregulation
of EPEC-induced actin rearrangements (Kenny, 2002;
Dean et al., 2005). Another two LEE effectors, Map
(mitochondrial-associated protein) and EspF target mito-
chondria where they interfere with organelle activity and/or
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shape (Kenny and Jepson, 2000; Nagai et al., 2005; Papa-
theodorou et al., 2006) but also possess functions inde-
pendent of mitochondrial targeting (Dean et al., 2005).
Relatively little is known about the LEE-encoded EspG,
EspH and EspZ effectors except that EspG plays a role,
along with its non-LEE homologue Orf3, in disrupting
microtubules while EspH impacts on the dynamics of
EPEC-induced cytoskeletal rearrangements (Matsuzawa
et al., 2004; Dean et al., 2005; Kanack et al., 2005).
Enteropathogenic E. coli is the prototypic member of
the attaching and effacing family of pathogens that carry
the LEE pathogenicity island, including the human patho-
gen enterohaemorrhagic E. coli (EHEC) with others colo-
nizing rabbits (REPEC), pigs (PEPEC), ruminants (EHEC)
and mice (Citrobacter rodentium). Importantly, 177
homologous ‘pathogenicity islands’ have been identified
in EHEC and EPEC genome sequences with the potential
to encode thousands of virulence factors (Perna et al.,
2001; Spears et al., 2006), with a recent study experimen-
tally defining 39 EHEC secreted/translocated proteins
(Tobe et al., 2006). Studies to date on non-LEE-encoded
effectors have revealed properties such as (i) targeting
the Golgi apparatus, (ii) interfering with cellular division
and (iii) playing roles in bacterial colonization (Chen and
Frankel, 2005; Dean et al., 2005).
An unexpected complexity in EPEC pathogenicity has
recently been revealed by the finding that LEE and non-
LEE effectors can function together, and in various com-
binations, to subvert host cellular processes (Matsuzawa
et al., 2004; Dean et al., 2005). For example, the LEE-
encoded Map, EspF, Tir and Intimin proteins act together
in different combinations to trigger several disease-
related changes including loss of absorptive microvilli
(Dean et al., 2006), rapid inactivation of the major small
intestinal water pump (Dean et al., 2006) and disruption of
epithelial barrier function (Dean and Kenny, 2004). Impor-
tantly, the postulated roles for Map and EspF in disrupting
barrier function have been validated in vivo (Shifflett et al.,
2005; Ma et al., 2006). However, this ability to compro-
mise barrier integrity raises the question of why EPEC
human infection is linked to a rather weak inflammatory
response compared with enteric pathogens such as Shi-
gella (Ashkenazi et al., 1983; Miller et al., 1994; Nataro
and Kaper, 1998) given the association of barrier dysfunc-
tion with inflammatory disease (Mullin et al., 2005). In vitro
studies using non-differentiated host cells have identified
EPEC flagellin as a potent pro-inflammatory mediator that
induces the expression, and subsequent release, of the
chemokine interleukin (IL)-8 that facilitates the recruitment
of inflammatory-associated immune cells such as poly-
morphonuclear leucocytes (Savkovic et al., 1996; 1997;
2001; 2003; Czerucka et al., 2001; Zhou et al., 2003;
Borthakur et al., 2006). Interestingly, while most of these
studies conclude that EPEC triggers a pro-inflammatory
IL-8 secretory response, one indicated that EPEC may
inhibit IL-8 secretion (Hauf and Chakraborty, 2003). This
possibility is supported by our findings that EPEC infec-
tion of differentiated Caco-2 cells prevents the production
of the antimicrobial reagent, nitric oxide, in response to
inflammatory cytokines (Maresca et al., 2005). Impor-
tantly, this inhibitory mechanism was related to a lack of
activation of the NF-kB transcriptional factor that is crucial
for inducing the expression of chemokines including IL-8,
inflammatory cytokines, adhesion molecules and other
antimicrobial reagents (Chen and Greene, 2004; Hayden
and Ghosh, 2004).
Induction of IL-8 secretion in response to foreign anti-
gens or cytokines requires ligand interaction with specific
receptors, such as the Toll-like receptor (TLR)-5 for flagel-
lin and tumour necrosis factor (TNF) receptor for TNFa,
triggering the recruitment of scaffolding, adaptor and
kinase proteins such as MyD88/IRAK/RIP and TRAF, to
induce the phosphorylation-related activation of the
IkB kinase (IKK) complex and mitogen-activated protein
(MAP) kinases (Kobayashi et al., 2004; Meylan and
Tschopp, 2005). IKK plays a crucial role in phosphorylat-
ing IkB, the cytoplasmic ‘inhibitory’ partner of NF-kB, trig-
gering its ubiquitination and degradation to release NF-kB
for translocation into the nucleus where its ability to tran-
scribe specific genes is controlled by DNA and protein
modifications (Chen and Greene, 2004; Hayden and
Ghosh, 2004). An additional level of control occurs
through the activation of MAP kinase members including
the extracellular-regulated kinase (ERK) 1/2, p38 and Jun
amino-terminal kinase (JNK) that regulate processes
such as accessory transcriptional factor function and
mRNA stability (Hoffmann et al., 2002; O’Neill, 2006).
In this paper we explore the idea, and provide evidence
for EPEC possessing a mechanism to prevent infected
epithelial cells from inducing the innate immune response
cascade in a model system representing the natural site
of infection. Insights are provided relating to the molecular
mechanism by which EPEC mediates this inhibition from
the bacterial and host perspectives. Importantly, we show
that the NF-kB-dependent innate immune response
pathway is effectively silenced before EPEC compro-
mises epithelial barrier function thereby providing a plau-
sible explanation for the absence of strong inflammatory
responses in infected humans.
Results
Maximal IL-8 secretory response requires EPEC
flagellin to access the basolateral surface
Studies with non-differentiated cells have identified flagel-
lin as the major EPEC antigen responsible for triggering
NF-kB-dependent secretion of the inflammatory-related
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chemokine IL-8. However, such a response may not occur
during apical infection of differentiated intestinal monolay-
ers as the host’s flagellin receptor, TLR-5, is considered to
be excluded from this surface in model systems (Gewirtz
et al., 2001). To investigate this, differentiated Caco-2
and T84 monolayers – models of small and large intes-
tinal epithelia respectively (Pinto et al., 1983; Dharm-
sathaphorn and Pandol, 1986; Delie and Rubas, 1997;
Kunzelmann and Mall, 2002) – were infected for 6 h with
wild-type EPEC or mutants deficient in TTSS-dependent
translocation (espB) or flagellin expression (flhDC) prior to
enzyme-linked immunosorbent assay (ELISA) quantifi-
cation of IL-8 levels in the basolateral compartment
(see Experimental procedures). Interestingly, while apical
infection of T84 cells failed to trigger significant increases
in IL-8 release above basal levels in uninfected cells,
introduction of the bacteria to the basolateral side induced
a ~30–50-fold increase (Fig. 1A). In contrast, infection at
either Caco-2 surface induced IL-8 secretory responses
though basolateral infection induced a more potent
(~2.5-fold greater) response than apical infection
(Fig. 1B). Importantly, IL-8 secretion was not induced in
either cell line with the flhDC mutant that delivers effector
proteins (data not shown) but does not express flagella
(Fig. 1A and B). Moreover, the significant reduction in IL-8
secreted levels following apical or basolateral infection
of Caco-2 cells with the wild-type strain, compared with
the effector delivery-defective (espB) mutant (Fig. 1B),
is supportive of the existence of a specific inhibitory
mechanism. Surprisingly, corresponding basolateral in-
fections of T84 cells failed to reveal any significant inhibi-
tion of flagella-dependent IL-8 secretion (Fig. 1A), linked
to a delay in the delivery and/or inhibitory activity of the
responsible effector molecule(s). Thus, this datum not
only identifies flagellin as the EPEC antigen responsible
for triggering IL-8 secretion in Caco-2 and T84 intestinal
models but clearly demonstrates a requirement for this
antigen to access the basolateral surface to stimulate the
most potent IL-8 secretory response. Moreover, the data
are consistent with EPEC possessing an effector delivery-
dependent mechanism that more rapidly inhibits flagellin-
induced IL-8 secretion from the small, than large intestinal
epithelia model systems.
Enteropathogenic E. coli abolishes the capacity of
differentiated Caco-2 cells to secrete IL-8 before
epithelial barrier function is compromised
Given the absence of a strong inflammatory response in
EPEC-infected humans, despite the pathogen’s ability to
disrupt barrier function, we examined the prediction that
loss of barrier integrity does not lead to increases in
flagellin-mediated IL-8 secretion. As previously published
(Dean and Kenny, 2004), a 6 h infection with the effector
delivery-defective mutant (espB) did not disrupt Caco-2
barrier function, in contrast to the wild-type strain where a
significant loss was first evident 3 h post infection with
progressively greater defects over the 6 h infection period
(Fig. 2A). Consistent with earlier results (Fig. 1B), very
low levels of IL-8 were detected in the basolateral well of
uninfected cells (Fig. 2B), with increased IL-8 levels fol-
lowing 6 h apical infections. Interestingly, apical infection
also triggered IL-8 release into the apical well, though the
levels are approximately one-third of those within the
basolateral well (Fig. 2B). Again consistent with previous
data (Fig. 1B), IL-8 levels were reduced in cells infected
with the wild-type strain compared with the espB mutant
Fig. 1. Maximal IL-8 secretory levels are dependent on access of
EPEC flagellin to the basolateral surface of differentiated epithelia.
The apical (AP; filled rectangles) or basolateral (BL; open
rectangles) compartments of differentiated (A) T84 or (B) Caco-2
cells were untreated (Uninfect.) or inoculated for 6 h with
pre-activated EPEC strains – wild type (WT), the espB effector
delivery-defective mutant or flhDC flagella-deficient mutant – prior
to measuring IL-8 levels in the basolateral compartment by
sandwich ELISA as described in Experimental procedures. Data
are from at least three independent experiments with error bars
revealing standard deviation. Statistical significance was evaluated
using Student’s t-test comparing data points relative to
corresponding uninfected controls. Additional comparison of linked
WT and espB data sets, indicated by lines, revealed no statistical
difference for T84-infected cells in contrast to Caco-2. *P < 0.05;
**P < 0.01; ***P < 0.001.
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(Fig. 2B). Infection for 2, 3, 4 and 6 h with the espB mutant
was associated with no, or small, changes in the asym-
metric distribution of IL-8 levels between both apical and
basolateral compartments. In contrast, there was a
gradual loss in the asymmetric distribution of IL-8
(observed 2 h post infection) over the following 4 h infec-
tion period with the wild-type strain (Fig. 2B). This loss in
asymmetric distribution parallels disruption of barrier func-
tion (Fig. 2A) indicating that the latter process, i.e. barrier
dysfunction enables macromolecules, such as IL-8, to
diffuse across the barrier. The clear absence of increased
IL-8 secretion in response to EPEC-mediated barrier dys-
function, which also allows access of host membrane
proteins to the apical surface (Muza-Moons et al., 2003),
is suggestive of a defect in inducing IL-8 secretion down-
stream of TLR-5/flagellin interaction.
To explore this premise we tested whether the cytokine
TNFa can induce IL-8 secretion from Caco-2 cells pre-
infected with wild-type EPEC or the espB effector
delivery-defective strain. Figure 2C shows that uninfected
cells and cells pre-infected with the espB mutant for 2, 3,
4 or 6 h secreted similar levels of IL-8 in response to the
basolateral addition of TNFa (Fig. 2C). In contrast, cells
pre-infected with wild-type EPEC for 3, 4 or 6 h, when
barrier function was detectably compromised (Fig. 2A),
failed to release significant amounts of IL-8 (Fig. 2C).
Moreover, significantly reduced levels of IL-8 was
secreted from cells pre-infected with wild-type EPEC for
2 h (~25 pg ml-1 compared with 100–180 pg ml-1 for unin-
fected and espB pre-infected cells; Fig. 2C), when barrier
dysfunction is not evident (Fig. 2A), clearly demonstrating
that EPEC possesses an effector delivery-dependent
Fig. 2. EPEC suppresses the ability of
Caco-2 cells to secrete IL-8 before epithelial
barrier function is compromised. The apical
surface of differentiated Caco-2 was left
uninfected (NI) or inoculated with pre-activate
wild-type EPEC (WT) or the espB effector
delivery-deficient mutant and (A) tight junction
integrity was monitored at the indicated time
points by measuring TER as described in
Experimental procedures. In (B) the levels of
IL-8 released into the basolateral (BL) or
apical (AP) compartments at the indicated
time points post inoculation were determined
by sandwich ELISA as described in
Experimental procedures. In (C) monolayers
were treated for 1 h with bactericidal levels of
gentamicin (100 mg ml-1 final concentration) to
end the infection at the indicated time points.
The following day (~16 h later) TNFa
(10 ng ml-1 final concentration) was added for
2 h to the basolateral compartment and the
levels of IL-8 released was measured by
sandwich ELISA. Data are from at least three
independent experiments with error bars
revealing standard deviation. Statistical
significance was evaluated using Student’s
t-test comparing data points relative to (B)
corresponding 2 h infection data point or (C)
to corresponding uninfected control. *P < 0.05;
**P < 0.01; ***P < 0.001.
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mechanism that inhibits IL-8 secretion from differentiated
Caco-2 before barrier function is compromised.
Role for non-LEE-encoded effectors in inhibiting IL-8
secretion
Given the TTSS effector delivery-dependent nature of the
inhibition, we screened available mutants to identify genes
involved in the inhibitory process. These analyses con-
firmed the essential role of genes required for effector
delivery, including espA and espB (Fig. 3), while dismiss-
ing crucial roles for the LEE-encoded EspF, EspG, EspH,
Map, Tir, Intimin and non-LEE-encoded EspG homologue,
Orf3 (Fig. 3, and data not shown). Given the redundant
nature of Map, EspF, Tir and Intimin in subverting host
cellular processes (Dean et al., 2005; 2006) we investi-
gated, but failed to identify cooperative roles using a qua-
druple (quad) mutant missing all four gene products
(Fig. 3). Cooperative roles for all known LEE-encoded
effectors and four non-LEE effectors were assessed with a
gorf 3Dcore strain in which a central ‘core’ region was
deleted from the LEE operon in an espGorf3 double mutant
background (see Experimental procedures) producing a
strain not expressing EspG, Orf3, EspH, CesF, Map, Tir,
CesT or Intimin. CesT is a chaperone required for the
efficient translocation and/or effector function of Map and
Tir (Abe et al., 1999; Creasey et al., 2003) and more
recently reported to be a chaperone for EspZ, NleA, NleF
and NleH (Thomas et al., 2005) while CesF is the EspF
chaperone (Elliott et al., 2002). Thus, while the gorf 3Dcore
mutant no longer encodes EspG, Orf3, EspH, Map, Tir or
Intimin, the additional absence of the CesT/CesF chaper-
ones is predicted to inhibit the translocation and/or effector
function of the EspF, EspZ, NleA, NleF and NleH proteins.
As this strain was as effective as wild-type EPEC at inhib-
iting IL-8 secretion (Fig. 3) this suggests that other non-
LEE-encoded effector(s) are responsible for the inhibitory
effect. Moreover, inhibition of IL-8 secretion by mutants
unable to disrupt barrier function (e.g. eae-negative
mutant) reveals that both processes are not linked.
Enteropathogenic E. coli prevents NF-kB transcriptional
factor activation and translocation into the nucleus
TNFa-mediated IL-8 secretion is dependent on a phos-
phorylation signalling cascade leading to the degradation
of the IkB inhibitory protein to release NF-kB for translo-
cation into the nucleus (Hoffmann et al., 2002; O’Neill,
2006). To investigate whether the IkB degradation or
NF-kB translocation processes are altered by EPEC, dif-
ferentiated Caco-2 cells were apically infected for 3 h with
the Intimin-negative eae strain that inhibits IL-8 secretion
(Fig. 3), without compromising barrier function (Dean and
Kenny, 2004), or the espA (effector delivery-defective)
mutant. The bacteria were killed (see Experimental pro-
cedures) and cells basolaterally treated with TNFa for 0,
15, 30 and 60 min before isolating ‘cytoplasmic’ and
‘nuclear’ fractions for Western blot analysis. Figure 4
reveals the rapid, but transient degradation of IkB and
subsequent accumulation of NF-kB (p65 isoform) in the
nuclear fraction of uninfected and espA pre-infected cells.
In contrast, cells pre-infected with the eae mutant showed
no such response, displaying patterns indistinguishable
from uninfected untreated cells (Fig. 4). Thus, EPEC inhi-
bition of IL-8 secretion is linked to the absence of NF-kB
translocation into the nucleus presumably related to the
observed defect in IkB degradation.
Enteropathogenic E. coli inhibits IKK-mediated
phosphorylation of IkB and NF-kB
IkB ubiquitination-dependent degradation requires phos-
phorylation by the IKK complex (Hoffmann et al., 2002).
To assess the effect of EPEC infection on this process,
IkB phosphorylation was induced with TNFa, in the pres-
ence or absence of the proteasomal inhibitor, MG132, in
cells pre-infected for 3 h with EPEC (eae or espA
mutants). Western analysis of cellular extracts for phos-
phorylated (on serine 32) or total IkB revealed rapid
phosphorylation- (Fig. 5A middle panel and graph) and
proteasomal-dependent degradation (Fig. 5A top versus
bottom panels) in uninfected and espA-infected cells. In
Fig. 3. Role of LEE-encoded effectors in inhibiting TNF-induced
IL-8 secretion. The apical surface of differentiated Caco-2 cells was
left uninfected (NI) or inoculated for 3 h with pre-activated EPEC –
wild type (WT), espB or espA (effector delivery-deficient), eae
(Intimin-deficient), quad (Map, EspF, Tir and Intimin-deficient) or
gorf3Dcore (deletion of LEE region carrying espH, cesF, map,
cesT, tir and eae genes in an espGorf3 double mutant background)
strains. Infected monolayers were treated for 1 h with bactericidal
levels of gentamicin (100 mg ml-1 final concentration) and the
following day (~16 h later) TNFa (10 ng ml-1 final concentration)
was added to the basolateral compartment for 3 h prior to
measuring the levels of IL-8 released into this compartment by
sandwich ELISA. Data are from at least three independent
experiments with error bars revealing standard deviation. Statistical
significance evaluated using Student’s t-test comparing data to
uninfected cells. *P < 0.05.
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contrast, pre-infection with the eae mutant prevented IkB
phosphorylation and thus degradation in response to
TNFa treatment (Fig. 5A).
To further assess the functionality of the IKK complex
we probed for the phosphorylation of NF-kB (p65 isoform)
on serine 536, as this modification is linked to its activa-
tion (Chen and Greene, 2004). Similar results were
obtained to those with IkB (Fig. 5A), as TNFa treatment of
uninfected or espA-infected cells triggered the phospho-
rylation of NF-kB, unlike cells pre-infected with the eae
mutant (Fig. 5B). Thus, the ability of effector translocation-
competent EPEC strains to prevent IL-8 secretion is
linked to a defect in IKK-mediated phosphorylation of IkB
and NF-kB thereby preventing both the activation and
nuclear translocation of NF-kB for gene transcription.
Enteropathogenic E. coli inhibits multiple MAP kinase
pathways
IL-8 secretion is also regulated at trans-activational and
mRNA stability levels through phosphorylation-related
activation of MAP kinase family members including
ERK1/2, JNK and p38 kinases (Chen and Greene, 2004;
Hayden and Ghosh, 2004). Assessment of the activation-
related phosphorylation of ERK1/2 and p38 Map kinases,
as well as the upstream MEK kinase, produced similar
results to those observed with IkB and NF-kB (Fig. 5).
Thus, TNFa treatment of uninfected and espA-infected
cells induced the phosphorylation of all three kinases
unlike cells pre-infected with the eae mutant where no
corresponding phosphorylation was detected (Fig. 5C and
D). The phosphorylation status of JNK was not assessed
as examination of total cellular levels revealed its unex-
pected degradation in response to TNFa treatment in cells
pre-infected with the eae mutant unlike uninfected cells or
those pre-infected with the espA mutant (data not shown).
As EPEC inhibit the phosphatidylinositol 3-kinase
(PI3-K)/Akt pathway in phagocytic cell lines (Celli et al.,
2001; Quitard et al., 2006), with this pathway implicated in
TNFa-mediated NF-kB activation (Reddy et al., 2000),
we assessed its activity in TNFa-treated differentiated
Caco-2 by probing for the activation-associated pho-
sphorylation of Akt on serine 473. Figure 5E illustrates
TNFa-dependent Akt phosphorylation in uninfected cells
and cells pre-infected with the espA (effector delivery-
defective) mutant. In contrast, cells pre-infected with the
eae mutant, which inhibits NF-kB-dependent IL-8 secre-
tion (Fig. 3), fail to induce Akt phosphorylation in response
to TNFa treatment. Thus, EPEC delivery of unidentified
effector proteins into differentiated Caco-2 cells inhibit the
phosphorylation-related activation of key kinases of the
IKK, Map kinase and PI3-K pathways that play crucial
roles in NF-kB-dependent transcription.
Discussion
It has been, and continues to be argued that EPEC inter-
action with epithelia cells leads to a pro-inflammatory
Fig. 4. EPEC prevents the activation and translocation of a transcriptional factor crucial to IL-8 gene transcription. The apical surface of
differentiated Caco-2 was left uninfected (NI) or inoculated for 3 h with pre-activated eae (Intimin-deficient) or espA (effector delivery-defective)
mutants prior to ceasing infections by treating for 1 h with bactericidal levels of gentamicin (100 mg ml-1 final concentration). TNFa
(10 ng ml-1 final concentration) was then added to the basolateral compartment for 0 (non-treated; NT), 15, 30 and 60 min before isolating
cytoplasmic and nuclear extracts as described in Experimental procedures. Equal amounts of protein extract were resolved by SDS-PAGE
(12%), transferred to nitrocellulose and probed with anti-IkB or anti-p65 antibodies as well as anti-actin and anti-Lamin A as loading
controls for cytoplasmic and nuclear proteins respectively. Provided blot is representative of those obtained from three independent
experiments.
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response (Savkovic et al., 1996; 1997; 2001; 2003;
Czerucka et al., 2001; Zhou et al., 2003; Borthakur et al.,
2006), though the extent of this may depend on a balance
between pro- and anti-inflammatory signals (Hauf and
Chakraborty, 2003; Chen and Frankel, 2005; Sharma
et al., 2006). However, this interpretation is based on
studies using non-differentiated epithelia cells where the
TLR-5 receptor that detects flagellin, the major EPEC
pro-inflammatory antigen, is not restricted from the site of
host–bacterial interaction unlike differentiated T84 epithe-
lia (Gewirtz et al., 2001). In support of this premise T84
cells (model of large intestinal epithelia) fail to secrete IL-8
in response to a 6 h apical EPEC infection while basolat-
eral infection triggers a potent IL-8 secretory response
(Fig. 1A). Thus, induction of an IL-8 pro-inflammatory
secretory response is dependent on EPEC antigens
gaining access to the basolateral membrane in this model
system. In contrast, apical infection of differentiated
Caco-2 cells (model of small intestinal epithelia) induced
IL-8 secretion but to a lesser extent (~2.5-fold less) than
corresponding basolateral infections (Fig. 1B). This datum
is consistent with in vivo data (Cario and Podolsky, 2000;
Bambou et al., 2004) indicating the presence of TLR-5 on
the apical membrane of small intestinal epithelia and sup-
ported by the finding that these IL-8 secretory responses
were dependent on EPEC-expressing flagella (Fig. 1).
Our finding contrasts with the report that addition of puri-
fied flagellin (from the closely related pathogen, EHEC) to
apical or basolateral surfaces induced similar levels of
IL-8 secretion (Miyamoto et al., 2006). This discrepancy
presumably reflects differences in antigen origin, concen-
tration and/or the presentational context of purified versus
bacterial-associated flagellin. Moreover, our models fail to
provide supportive evidence for other non-flagellin anti-
gens in stimulating IL-8 secretion (Sharma et al., 2006),
possibly reflecting differences in cell types (Caco-2/T84 in
this study versus HT-29) or an apparent non-differentiated
status of the HT-29 cells (Zweibaum et al., 1985).
Fig. 5. EPEC inhibits phosphorylation-
associated activation of IKK, ERK, p38 and
PI3-K pathways. Differentiated Caco-2 cells
were (B–E) left untreated or (A) pretreated, or
not, with the proteasome inhibitor MG132
(50 mM final concentration) for 1 h prior to 3 h
apical inoculations with pre-activated eae
(Intimin-deficient) or espA (effector
delivery-defective) mutants. Infections were
stopped by 1 h treatment with bactericidal
levels of gentamicin (100 mg ml-1 final
concentration) prior to adding TNFa
(10 ng ml-1 final concentration) for 30 min to
the basolateral compartment of uninfected
(NI) or infected cells followed by the isolation
of Triton X-100 (1% v/v) soluble extracts as
described in Experimental procedures. Equal
protein loadings were resolved by SDS-PAGE
(12%), transferred to nitrocellulose and
probed with antibodies specific to (A) IkB or
its phosphorylation on serine 32, P-IkB, (B)
p65 isoform of NF-kB or its phosphorylation
on serine 536, P-p65, (C) p38 Map kinase or
its phosphorylation on threonine180/
tyrosine182, P-p38, (D) ERK1/2 MAP kinase
or phosphorylation on threonine202/
tyrosine204 (P-Erk) and MEK MAP kinase
kinase or phosphorylation on serine 221
(P-MEK) respectively, and (E) Akt or its
phosphorylation on serine 473 (P-Akt). Linked
graphs show relative amplitude of
phosphorylated bands (arbitrary units)
compared with those of the corresponding
uninfected untreated cells obtained by
densitometry examination of data from three
independent experiments with standard
deviation indicated by error bars. Statistical
significance evaluated using Student’s t-test
comparing data with that of the corresponding
uninfected untreated cells. *P < 0.05;
**P < 0.01; ***P < 0.001.
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However, our studies clearly identify flagellin as the EPEC
antigen triggering IL-8 secretion from differentiated
Caco-2 and T84 cells, with basolateral infections trigger-
ing more potent IL-8 secretory responses than apical
infections.
The finding that significantly less IL-8 was released
following apical or basolateral infection of Caco-2 cells
with the wild-type strain compared with the effector
delivery-defective mutant (Fig. 1B) supported the exist-
ence of an effector-dependent mechanism to antagonize
flagellin-induced IL-8 secretion (Sharma et al., 2006).
This premise was further supported by the fact that
EPEC TTSS-dependent disruption of barrier function
(Fig. 2A), which facilitates the movement of ions, macro-
molecules (including IL-8; Fig. 2B) and membrane pro-
teins to the apical surface (Muza-Moons et al., 2003),
was not linked to increases in IL-8 secretion levels
(Fig. 2B). Moreover, cells whose barrier function had
been compromised by EPEC failed to secrete IL-8 in
response to the basolateral addition of TNFa, unlike
uninfected cells or those infected with an effector
delivery-defective mutant (Fig. 2B and C). Informatively,
cells pre-infected with the wild-type strain for 2 h, before
barrier dysfunction was evident (Fig. 2A), released four
to five times less IL-8 in response to TNFa than unin-
fected cells or those pre-infected with the effector
delivery-defective mutant (Fig. 2B). Crucially, cells pre-
infected with the eae (Intimin-deficient) mutant, which
does not disrupt barrier function (Dean and Kenny,
2004), failed to secrete IL-8 in response to the basolat-
eral addition of TNFa (Fig. 3), flagellin and other unde-
fined non-flagellar EPEC antigens (antigens released
following gentamicin killing of the flhDC mutant that
induce potent IL-8 secretory responses in uninfected
cells; data not shown). The viability of these pre-infected
cells was evidenced by retention of tight junction integrity
24 h after ceasing bacterial infection as well as the ability
of such cells to phosphorylate the STAT-1 transcriptional
factor in response to cytokines (Maresca et al., 2005). It
should be stressed that EPEC-mediated barrier dysfunc-
tion and inhibition of IL-8 secretion are unlinked, as the
former (Dean and Kenny, 2004) but not the latter is
dependent on LEE-encoded Intimin protein (Fig. 3).
Thus, this datum reveals that EPEC interaction with the
apical surface of differentiated Caco-2 cells inactivates
the capacity of host Toll-like and TNF receptors to induce
IL-8 secretory responses before other EPEC effector-
mediated signalling has compromised barrier function.
The above finding has important implications in relation
to the infection process as it provides a plausible expla-
nation to why EPEC infection of humans is only associ-
ated with rather weak inflammatory responses (Ashkenazi
et al., 1983; Miller et al., 1994; Nataro and Kaper, 1998)
despite the pathogen’s in vitro and in vivo defined capac-
ity to disrupt epithelial barrier function (Dean and Kenny,
2004; Shifflett et al., 2005; Ma et al., 2006). However, this
raises a question on why closely related members includ-
ing rabbit-EPEC and mouse-specific Citrobacter roden-
tium are associated with inflammatory diseases. This may
be due to differences in host physiology, infection site or
the number, amino acid composition and strain-specific
nature of some TTSS-dependent effectors (Perna et al.,
1998; Deng et al., 2004; Tobe et al., 2006). Thus, it is
likely that strains have acquired and/or adapted specific
effectors, or encoding functions, to mediate distinct strat-
egies that maximize their survival, replication and dis-
semination potential in their host.
While our studies clearly demonstrated the TTSS
delivery-dependent nature of the inhibition of IL-8 secre-
tion, we failed to identify the responsible effector(s).
However, we ruled out important roles, individual or coop-
erative, for the LEE-encoded Map, EspF, Tir effectors as
well as the Intimin membrane protein (Fig. 3) that function
together in various combinations to trigger disease-
related changes in cell physiology (Dean and Kenny,
2004; Dean et al., 2006). Moreover, roles were not
detected for LEE-encoded EspG and EspH proteins, the
non-LEE EspG homologue Orf3 or the non-LEE non-
TTSS-secreted EspC enterotoxin (Navarro-Garcia et al.,
2004) (Fig. 3; data not shown). In addition, our studies
are consistent with no significant role for 11 effectors
(all known LEE-encoded effectors, Intimin and the non-
LEE-encoded Orf3, NleA, NleF and NleH effectors) in the
inhibitory process. However, this premise is based on the
rationale that mutants missing the CesT and CesF chap-
erones required for the efficient translocation of Map/Tir
and EspF into host cells, respectively, fail to induce cellu-
lar changes linked to these effectors (Abe et al., 1999;
Elliott et al., 2002; Creasey et al., 2003) and thus the
supposition that EspZ, NleA, NleF and NleH would have
similar defects given that CesT is reported to be their
chaperone (Thomas et al., 2005). Thus, deleting the LEE
region encompassing espH, cesF, map, tir, cesT and eae
genes from an espG/orf3 double mutant background
removes the genes encoding EspG, Orf3, EspH, Map, Tir
and Intimin, with the additional absence of genes encod-
ing CesT/CesF inhibiting EspF, EspZ, NleA, NleF and
NleH effector translocation and/or function. Thus, our
results suggest that the inhibitory effect is likely to be
mediated by one or more of an increasing list of non-LEE
TTSS-dependent effectors (Spears et al., 2006; Tobe
et al., 2006).
We also provided important new insights into the inhibi-
tory mechanism within a model representing the natural
infection site of EPEC and which, consistent with other
studies (Hauf and Chakraborty, 2003; Maresca et al.,
2005), includes a central role for the NF-kB transcription
factor that plays a crucial role in inducing innate immune
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responses (Chen and Greene, 2004; Hayden and Ghosh,
2004). However, our investigations have unveiled a more
complicated situation whereby EPEC inhibits multiple
phospho-relay cascades involved in the activation of
kinases of the IKK, MAP kinase (ERK1/2, p38 and JNK)
and PI3-K pathways (Figs 4 and 5) linked to NF-kB
nuclear translocation, transcriptional activation, mRNA
stability, protein expression and delivery (Hoffmann et al.,
2002; Chen and Greene, 2004; Hayden and Ghosh, 2004;
O’Neill, 2006). Thus, while we demonstrate that pre-
infection of host cells with an effector delivery-defective
mutant had no significant impact on the ability of TNFa to
activate these pathways, cells pre-infected for 3 h with
effector delivery-competent strains were effectively unre-
sponsive to this cytokine. Moreover, the inhibitory mecha-
nism was linked to a lack of phosphorylation-associated
activation of IKK, MAP kinase (ERK1/2, p38), PI3-K,
NF-kB and IkB (Figs 4 and 5). Unexpectedly the MAP
kinase, JNK, was found to be degraded in a proteasomal-
independent manner in cells pre-infected with the eae
mutant prior to TNFa treatment, unlike uninfected cells or
those pre-infected with an effector delivery-defective
strain (data not shown). The non-responsiveness of these
signalling pathways would explain why various bacterial
antigens (released from gentamicin-killed EPEC) and
cytokines (TNFa, IL-1b, IFNg) fail to induce NF-kB-
dependent IL-8 secretion (Fig. 2) or NO production
(Maresca et al., 2005). Thus, it would appear that EPEC
rapidly desensitizes infected cells from responding to
external signals that would normally trigger NF-kB-
dependent innate immune responses. As suggested
above, this might explain why EPEC infection of humans
is not associated with strong inflammatory responses
linked with breaches in epithelial barrier integrity (Mullin
et al., 2005). Inhibiting NF-kB-dependent function not only
prevents the induction of IL-8 (this study) and NO pro-
duction (Maresca et al., 2005) but should also inhibit
the induced expression of other chemokines, cytokines,
adhesion molecules, ion transporters and antimicrobial
enzyme activities (Chen and Greene, 2004; Hayden and
Ghosh, 2004) thereby hindering the host’s capacity to
rapidly counter EPEC infection.
Given the essential nature of NF-kB activity in the
innate immune response it is not surprising that many
pathogens have evolved mechanisms that partially or
completely alter its activity. Indeed, pathogenic factors
can interfere at specific or multiple steps of one or more of
the above described pathways by providing factors often
structurally and/or functionally analogous to host regula-
tory proteins (Tato and Hunter, 2002). It is evident from
our studies that EPEC inactivates several pathways that
regulate NF-kB function akin to the Yersinia YopJ TTSS-
injected effector that transacetylates residues linked to
phosphorylation-related activation of MAP kinase kinase
members (Mukherjee et al., 2006). However, it is unlikely
that EPEC utilizes a similar mechanism as YopJ family
members have a conserved catalytic domain with no
homologues reported for EPEC or EHEC (Perna et al.,
2001; Tobe et al., 2006). Intriguingly, EHEC encodes
several effectors (NleH) that share homology to the Shi-
gella OspG TTSS-injected effector protein that interferes
with NF-kB signalling (Kim et al., 2005). However, these
are unlikely to represent the EPEC inhibitory factor(s) as
(i) the espGorf3Dcore mutant inhibits IL-8 secretion
although it should be defective in NleH translocation (see
above, note only one of two predicted EPEC NleH genes
appears intact) and (ii) OspG function to delay, not
prevent IkB degradation. Studies are currently underway
to define the effector molecule(s) responsible for inhibiting
the NF-kB-related pathways and the molecular mecha-
nism of inhibition.
In summary, our studies with the extensively used
Caco-2 model of small intestinal epithelia clearly demon-
strates that apical infection with EPEC triggers a rapid
TTSS-dependent inhibition of signalling pathways crucial
for the induction of the innate immune response respon-
sible for producing chemokines, cytokines and anti-
microbial activities. This work not only argues against a
role for 11 known effector proteins but also unveils a
complex inhibitory mechanism encompassing the IKK,
MAP (ERK1/2, p38, JNK) kinase and PI3-K signalling
pathways. Importantly, the inactivation of these pathways
precedes EPEC-induced barrier disruption providing a
plausible explanation for the weak inflammation response
in infected humans.
Experimental procedures
Bacterial strains, growth condition and cell culture
Bacterial strains used in this study are listed in Table 1. All strains
were grown from single colonies on Luria–Bertani (LB) plates in
LB broth plus or minus nalidixic acid (25 mg ml-1 final) at 37°C in
a 5% CO2 atmosphere overnight without shaking. Caco-2 cells
(ATCC No HTB-37) and T84 cells (ATCC No CCL-248) were
grown at 37°C with 5% CO2 in Dulbecco’s minimal Eagle’s
medium (DMEM) supplemented with 10% heat-inactivated fetal
calf serum, 1% nonessential amino acids, 2 mM L-glutamine and
1% antibiotics (penicillin/streptomycin, 100 units ml-1 final con-
centration; Sigma). Cells were used between passages 10 and
40 and seeded onto 1 (0.45 mm pores) or 4.5 (3 mm pores) cm2
Transwell-Clear inserts (Corning) at a density of 250 000 cells
cm-2. Cells were differentiated over a 7 day period with differen-
tiation, which depends on tight junction formation, routinely veri-
fied using an EVOM voltohmeter (World Precision Instruments) to
measure transepithelial electrical resistance (TER) across the
junctions before and after infection.
Generation of espG/orf3Dcore mutant
An ~2 kb region immediately upstream of espH was PCR amplify
using the high-fidelity Pfu polymerase (Promega) and an
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oligonucleotide pair (Table 1) incorporating BglII/EcoRI sites at
the 3′ end. Similarly, an ~2 kb region immediately downstream of
the eae (Intimin) gene was amplified with an oligonucleotide pair
(Table 1) incorporating BglII/EcoRI sites at the 5′ end and an XhoI
site at the 3′ end. The A-addition kit (Qiagen) was used to add
A-tails to the PCR fragments prior to ligating into pDrive (Qiagen).
The upstream region was cloned on an XbaI (upstream of 5′ end
within cloning vector)/EcoRI fragment together with the down-
stream EcoRI/XhoI fragment into the XbaI/SalI (SalI compatible
with XhoI) sites of the pKNG101 suicide vector (Kaniga et al.,
1991). The plasmid was isolated from E. coli SY327 and trans-
formed into strain SM10 prior to conjugating with the EPEC
espG/orf3 mutant, as previously described (Kenny et al., 1997),
to introduce the streptomycin-resistant (50 mg ml-1 final concen-
tration) suicide plasmid. Streptomycin-resistant clones having
undergone allelic exchange leading to the replacement of the
wild-type locus with that missing the espH, cesF, map, cesT, tir
and eae genes were selected on LB plates without NaCl contain-
ing 5% sucrose, as previously described (Kaniga et al., 1991).
SDS-PAGE Coomassie and Western blot analyses confirmed
that the espG/orf3Dcore mutant clone expressed and secreted
wild-type levels of the EspA,B,D translocator proteins in the
absence of Map, Tir or Intimin with EspF secreted levels reduced
due to the absence of its chaperone, CesF (data not shown).
Infection protocol
At least 2 h before infection the medium in the apical and
basolateral compartments was replaced with DMEM (without
supplements). Overnight bacterial cultures were diluted (1:10) in
non-supplemented DMEM and left at 37°C in 5% CO2 atmo-
sphere for 3 h to pre-activate the bacteria (Dean et al., 2006), by
which time the OD600 typically reached 0.2–0.3. An appropriate
volume for a final infection of 50 bacteria per host cell was added
to the apical or basolateral compartment, as indicated, for various
times. For basolateral infections (3 mm pore inserts), bacteria
were added for 1 h (total volume 100 ml) to the porous surface of
inverted inserts before re-inverting into fresh DMEM for continued
incubation. In some experiments, infection was stopped by the
addition of gentamicin (100 mg ml-1 final concentration) for 1 h
before the basolateral addition of TNFa (10 ng ml-1 final concen-
tration), bacterial supernatants or gentamicin-killed EPEC.
Measurement of IL-8 secretion levels
The level of IL-8 released into the apical and/or basolateral
compartments was assessed using an ELISA kit (DB Bio-
sciences) following the manufacture’s directions.
Isolation of soluble, cytoplasmic and nuclear extracts
Following bacterial infection and/or stimulation, inserts were
washed with cold PBS and cells lysed in 1% Triton X-100/PBS
buffer containing a cocktail of protease inhibitors (Sigma; P8340
1:1000 dilution), 1.25 mM sodium fluoride (NaF), 1 mM sodium
orthovanadate (NaVO4) and 1 mM phenylmethylsulphonylfluo-
ride (PMSF). Centrifugation (13 000 g, 4°C, 5 min) pelleted bac-
teria, host nuclei and cytoskeleton with the remaining ‘soluble’
fraction resuspended in Laemmli sample buffer (Laemmli,
1970). In other experiments washed cells were scraped into cold
PBS before resuspending in a buffer containing 10 mM Hepes
pH 7.8, 10 mM KCl, 2 mM MgCl2, 0.1 mM EDTA, 1 mM DTT,
1.25 mM NaF, 1 mM NaVO4, 1 mM PMSF for 15 min on ice.
Nonidet P-40 (0.5% final concentration) was added and the
mixture vortexed for 15 s prior to centrifugation (13 000 g, 4°C,
30 s) to pellet the host nuclei. The soluble supernatants samples
were resuspended in Laemmli sample buffer. The pelleted
nuclei were resuspended in a buffer containing 50 mM Hepes
pH 7.8, 50 mM KCl, 300 mM NaCl, 10% glycerol, 0.1 mM EDTA,
1 mM DTT, 0.2 mM NaF, 0.2 mM NaVO4, 1 mM PMSF and agi-
tated for 20 min at 4°C, vortexing briefly every 5 min. The
Table 1. EPEC strains and oligonucleotides used in this study.
Strain Deficiency Reference
E2348/69; O127:H6 serotype None Levine et al., (1985)
sep-2 (CVD452) TTSS Jarvis et al., (1995)
eae mutant (CVD206) Intimin Donnenberg and Kaper (1991)
espA mutant EspA Kenny et al. (1996)
espB mutant (UMD864) EspB Donnenberg et al. (1993)
espC mutant EspC Stein et al. (1996)
espF mutant EspF Warawa et al. (1999)
espG/orf3 mutant EspG/Orf3 Elliott et al. (2001)
espH mutant EspH Tu et al. (2003)
map mutant Map Kenny and Jepson (2000)
tir mutant Tir Kenny et al. (1997)
quad mutant Tir/Intimin/EspF/Map Quitard et al. (2006)
flhDC mutant (DF971) Flagella Ilan Rosenshine
espG/orf3Dcore EspG/Orf3/EspH/CesF/Map/CesT/Tir/Intimin This study
Oligonucleotide Sequence (5′ to 3′ with incorporated restriction sites underlined or in italics)
UpcorePS GTTGTTACATCGGGAGGATTTGCGTGCGGGCGGCA
UpcoreNS CGGAATTCAGATCTGATTAATCACATACTACGCTAAAGT
DowncorePS AGGAATTCAGATCTAATGCTTATGCCACTTGTGTAAAATAAA
DowncoreNS2 GCAGCTCGAGCATTTCATTGAGCACCTTCTCGA
Note all mutants except espC, espH are nalidixic resistant with a nalidixic resistant isolate of the flhDC mutant selected for these studies.
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samples were centrifuged (13 000 g, 4°C, 5 min) and superna-
tants containing nuclear proteins resuspended in Laemmli
sample buffer. Samples were boiled for 5 min and analysed
immediately or stored at -80°C.
Immunoblotting
Equal volumes of cellular samples were resolved by SDS-PAGE
(12%), transferred to nitrocellulose and blocked for 1 h in 5%
‘Blotto’ skimmed milk powder in PBS. Blots were incubated over-
night at 4°C with gentle rocking in a 5% bovine serum albumin/
PBS solution containing antibodies (from Santa Cruz) against
IkBa, p38, NF-kB (p65 isoform) or (from Cell Signalling)
phospho-NF-kB (p65 isoform; Ser 536), phospho-IkBa (Ser 32),
phospho-p38 (Thr180/Tyr182), ERK, phospho-ERK (Thr202/
Tyr204), MEK and phospho-MEK (Ser221). Extensively washed
blots were incubated with the appropriate horseradish
peroxidase-conjugated secondary antibody and developed in
Super Signal West Pico chemiluminescent substrate (Pierce)
with the signal detected on Hyperfilm ECL (Amersham Bio-
sciences) following manufactures’ recommendations.
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